You have 9 free searches left this month | for more free features.

CK0804

Showing 1 - 18 of 18

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Myelofibrosis Trial in Houston (CK0804)

Not yet recruiting
  • Myelofibrosis
  • CK0804
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Jun 28, 2022

NSCLC Trial in Worldwide (MEDI4736, PLACEBO)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • Chandler, Arizona
  • +235 more
Jan 4, 2023

Carcinoma, Renal Cell Trial in Worldwide (Belzutifan, Lenvatinib, Cabozantinib)

Recruiting
  • Carcinoma, Renal Cell
  • Chandler, Arizona
  • +176 more
Jan 19, 2023

NSCLC Trial in Worldwide (DS-1062a, Docetaxel)

Recruiting
  • Non-small Cell Lung Cancer
  • Chandler, Arizona
  • +203 more
Jun 9, 2022

HER2-positive Breast Cancer Trial in Worldwide (tucatinib, , T-DM1)

Recruiting
  • HER2-positive Breast Cancer
  • Mobile, Alabama
  • +262 more
Jan 26, 2023

Breast Cancer Trial in Worldwide (Amcenestrant-matching , SAR439859, Palbociclib)

Active, not recruiting
  • Breast Cancer
  • Amcenestrant-matching placebo
  • +5 more
  • Daphne, Alabama
  • +299 more
May 5, 2022

Clear Cell Renal Cell Carcinoma Trial in Worldwide (Belzutifan, Pembrolizumab, Placebo)

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • Duarte, California
  • +250 more
Jan 27, 2023

XIENCE PRIME SV Everolimus Eluting Coronary Stent Japan Post

Completed
  • Ischemic Heart Disease
  • +4 more
  • XIENCE PRIME SV Everolimus Eluting Coronary Stent
  • Chiba, Japan
  • +32 more
Apr 12, 2021

Perioperative/Postoperative Complications Trial in München

Active, not recruiting
  • Perioperative/Postoperative Complications
    • München, Bavaria, Germany
      Klinikum Rechts der Isar, Technische Universität München
    Jul 31, 2020

    Atherosclerotic Cardiovascular Disease Trial in Worldwide (Lp(a) Screening)

    Recruiting
    • Atherosclerotic Cardiovascular Disease
    • Lp(a) Screening
    • Birmingham, Alabama
    • +670 more
    Feb 1, 2023

    Diabetic Kidney Disease Trial in Worldwide (Finerenone (BAY94-8862), Placebo)

    Completed
    • Diabetic Kidney Disease
    • Finerenone (BAY94-8862)
    • Placebo
    • Birmingham, Alabama
    • +974 more
    Apr 13, 2022

    Small Cell Lung Cancer Trial in Worldwide (Placebo for dexamethasone, Placebo for rovalpituzumab tesirine, Rovalpituzumab

    Terminated
    • Small Cell Lung Cancer
    • Placebo for dexamethasone
    • +3 more
    • Huntsville, Alabama
    • +307 more
    Jul 28, 2021

    Prevention of Stroke or Systemic Embolism, Atrial Fibrillation Trial in Worldwide (Asundexian (BAY2433334), Apixaban, Asundexian

    Recruiting
    • Prevention of Stroke or Systemic Embolism
    • Atrial Fibrillation
    • Asundexian (BAY2433334)
    • +3 more
    • Dothan, Alabama
    • +1128 more
    Jan 5, 2023

    Chronic Kidney Disease Trial in Worldwide (Finerenone (BAY94-8862), Placebo)

    Completed
    • Chronic Kidney Disease
    • Finerenone (BAY94-8862)
    • Placebo
    • Birmingham, Alabama
    • +977 more
    Jun 29, 2021

    Hepatobiliary Disorders, Non-alcoholic Steatohepatitis Trial in Worldwide (Semaglutide, Placebo)

    Completed
    • Hepatobiliary Disorders
    • Non-alcoholic Steatohepatitis
    • Birmingham, Alabama
    • +157 more
    Nov 15, 2021

    Moderate to Very Severe COPD Trial in Worldwide (Benralizumab Arm A, Benralizumab Arm B, Placebo)

    Completed
    • Moderate to Very Severe Chronic Obstructive Pulmonary Disease
    • Benralizumab Arm A
    • +2 more
    • Andalusia, Alabama
    • +408 more
    Jun 12, 2019

    Opioid-use Disorder, Pain, Acute, Surgery Trial (buprenorphine/naloxone)

    Unknown status
    • Opioid-use Disorder
    • +2 more
    • (no location specified)
    Oct 5, 2018

    Diabetes, Type 2 Trial in Worldwide (Ticagrelor 60 mg, Ticagrelor )

    Completed
    • Diabetes Mellitus, Type 2
    • Ticagrelor 60 mg
    • Ticagrelor placebo
    • Alexander City, Alabama
    • +1241 more
    Mar 4, 2020